Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-01-01 @ 3:17 PM
Study NCT ID:
NCT00892658
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2009-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UHN REB 08-0761-C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None